Objectives To assess the reasons to use, reasons they liked, satisfaction with, and
possibilities of recommendation to other women of the levonorgestrel 52‐mg intrauterine …

Objective To assess the reasons provided by women for choosing the use of the 52 mg
levonorgestrel intrauterine system (LNG‐IUS) as a contraceptive method. Methods We …

Objectives To identify the characteristics of an international population of women using the
levonorgestrel-releasing intrauterine system (LNG-IUS) and their experiences with this …

Objective To characterise patient satisfaction 6 and 12 months after insertion of a 52 mg
levonorgestrel‐releasing intrauterine system (LNG-IUS) in Portuguese women. Study design …

OBJECTIVE: To assess the acceptability of the levonorgestrel-releasing intrauterine system
(LNG-IUS, Mirena®) in the long-term treatment of heavy menstrual bleeding. STUDY …

Aim Satisfaction with a contraceptive method constitutes an important factor in its
acceptance and long‐term use. The objective of this study was to assess the relationship …

Objectives The aims of the study were to assess the number of insertions per month of the
52 mg levonorgestrel-releasing intrauterine system (LNG-IUS) and gauge the knowledge …

Background. There is growing evidence of women's dissatisfaction with the levonorgestrel-
releasing intrauterine system (LNG-IUS) because of a high incidence of adverse effects …

OBJECTIVE: The study was conducted to identify predictors of oligoamenorrhea at 12
months in levonorgestrel-releasing intrauterine system (LNG-IUS) users. DESIGN: A 12 …

Purpose Current research fails to adequately inform about the differential use of available
levonorgestrel-releasing intrauterine systems (LNG-IUSs) in real life. Aim of our study was to …